Cycad Group LLC — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Intarcia TherapeuticsDec 2016
Biopharmaceutical company developing innovative therapies for chronic diseases using proprietary drug delivery systems.
BiotechBoston, US
James Ahlers(Executive Officer)Irwin Scher(Director)John Yee(Executive Officer)Sunita Zalani(Executive Officer)Raymond T. Keane(Executive Officer)Emad Rizk(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.